Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
NexPlasmaGen logo — A cold plasma company dedicated to fight cancer

NexPlasmaGen

A cold plasma company dedicated to fight cancer

Founded 2008 Canada Montreal, Canada 8 employees Unknown Health and Wellness, Medical Devices

General Information

Company Name NexPlasmaGen
Founded Year 2008
Location Canada Montreal, Canada +1
Employees 8
Industries Health and Wellness, Medical Devices
Funding Stage Unknown
Social

Get notified when NexPlasmaGen moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About NexPlasmaGen

NexPlasmaGen is a Canadian-based company that specializes in developing noninvasive plasma technologies to combat cancer. Founded in 2008, the company's mission revolves around reducing breast cancer recurrence rates and improving patients' survival rates at various stages of the disease. Their innovative plasma technology has shown promise in preclinical trials and is positioned as safe, efficient, versatile, and portable. In addition to enhancing patient outcomes, NexPlasmaGen aims to curtail the financial burden associated with cancer recurrence for both hospitals and patients. As of now, the company is preparing for safety clinical trials slated for 2023. With a focus on the Health and Wellness and Medical Devices sectors, NexPlasmaGen is poised to make significant strides in the fight against cancer.

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1 •••• •••• 01 May 2023
Spinout •••••• 2 •••• •••• 01 Jan 2008

NexPlasmaGen Alternatives & Competitors

NexPlasmaGen vs
Vuja De Sciences
Vuja De Sciences

Vuja De is dedicated to developing cancer metastasis treatments that prevent cancer progression and...

Series Unknown
7 employees
Biotechnology, Health Care
NexPlasmaGen vs
Canadian Cancer Trials Group
Canadian Cancer Trials Group Canada

Trials That Matter

107 employees
NexPlasmaGen vs
Signature Diagnostics GmbH
Signature Diagnostics GmbH

Signature Diagnostics AG, established in 2004 and located in Potsdam, Germany, specializes in transl...

Series C
Biotechnology, Health Care

FAQ About NexPlasmaGen

A cold plasma company dedicated to fight cancer
NexPlasmaGen was founded in 2008.
NexPlasmaGen is headquartered in Montreal, Canada.
NexPlasmaGen operates in the following industries: Health and Wellness, Medical Devices.
NexPlasmaGen has approximately 8 employees.
NexPlasmaGen has completed 2 funding rounds. The latest funding stage is Unknown.
Top alternatives and competitors to NexPlasmaGen include Vuja De Sciences, Canadian Cancer Trials Group, Signature Diagnostics GmbH, TCR Cure, TFC Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
NexPlasmaGen and Vuja De Sciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors NexPlasmaGen and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes